Experts Urge FDA To Use Databases, Post-Market Monitoring To Boost Safety

2007 ◽  
Vol 2 (6) ◽  
pp. 279-280
Author(s):  
Jeffrey L. Fox
2004 ◽  
Vol 33 (4) ◽  
pp. 333-335
Author(s):  
S. Bardócz ◽  
Á. Pusztai

2008 ◽  
Vol 46 (1) ◽  
pp. 9-33 ◽  
Author(s):  
P. Hepburn ◽  
J. Howlett ◽  
H. Boeing ◽  
A. Cockburn ◽  
A. Constable ◽  
...  

2014 ◽  
Vol 58 (1) ◽  
pp. 109-128
Author(s):  
Odile Juliette Lim Tung

AbstractThis article analyses the Mauritian regulatory framework on genetically modified organisms (GMOs) and highlights its shortcomings, with the aim of improving the regulation of the approval and monitoring of the use of GMOs in Mauritius. It examines key issues regarding the application for a GMO permit, risk assessment requirements, identification and labelling obligations, post-market monitoring, and liability and redress in the case of damages. There is a need for greater public participation in decision-making on the approval of GMO permits and the monitoring stage procedure, specific civil liability provisions for damage as well as regulation of the coexistence of genetically modified (GM) and non-GM crops in the Mauritian biosafety framework. Pending the proclamation of the entire Mauritian GMO Act 2004, relevant transitional provisions should also be provided. Beyond legal provisions on biosafety, a national policy on GM products and GMO-related activities should be elaborated.


Sign in / Sign up

Export Citation Format

Share Document